1
A CRF02_AGa CRF02_AGa CRF02_AGaCRF02_AG CRF22_01A1 CRF02_AG CRF02_AG CRF36_cpxb/F2b CRF02_AG NDc CRF02_AG CRF02_AG ND NDc cCRF02_AG CRF01_AE CRF02_AG CRF02_AG CRF01/F CRF02_AG A-likeb CRF02_AG CRF02_AG CRF01_AE CRF02_AG NDc CRF02_AGNDc CRF02_AG A1 A1 F G A1 CRF02_AG CRF02_AG CRF02_AG CRF02_AG CRF02_AG CRF02_AG CRF02_AG CRF02_AG CRF37_cpx F CRF01_AE CRF37_cpx Ub DCRF02_AGa CRF02_AG URF A1 URF G URF
1
Ologyj.com/content/10/1/Page 2 ofparticularly relevant because they encode highly immunogenic proteins that are frequently included in candidate vaccines [9-11]. We sequenced 50 full length HIV-1 gag and 55 nef genes from 59 HIV-infected blood donors in Cameroon. To obtain a phylogenetic view of Cameroonian HIV diversity that explicitly accounted for the confounding effects of recombination, we pe
1
A CRF02_AGa CRF02_AGa CRF02_AGaCRF02_AG CRF22_01A1 CRF02_AG CRF02_AG CRF36_cpxb/F2b CRF02_AG NDc CRF02_AG CRF02_AG ND NDc cCRF02_AG CRF01_AE CRF02_AG CRF02_AG CRF01/F CRF02_AG A-likeb CRF02_AG CRF02_AG CRF01_AE CRF02_AG NDc CRF02_AGNDc CRF02_AG A1 A1 F G A1 CRF02_AG CRF02_AG CRF02_AG CRF02_AG CRF02_AG CRF02_AG CRF02_AG CRF02_AG CRF37_cpx F CRF01_AE CRF37_cpx Ub DCRF02_AGa CRF02_AG URF A1 URF G URF
1
A CRF02_AGa CRF02_AGa CRF02_AGaCRF02_AG CRF22_01A1 CRF02_AG CRF02_AG CRF36_cpxb/F2b CRF02_AG NDc CRF02_AG CRF02_AG ND NDc cCRF02_AG CRF01_AE CRF02_AG CRF02_AG CRF01/F CRF02_AG A-likeb CRF02_AG CRF02_AG CRF01_AE CRF02_AG NDc CRF02_AGNDc CRF02_AG A1 A1 F G A1 CRF02_AG CRF02_AG CRF02_AG CRF02_AG CRF02_AG CRF02_AG CRF02_AG CRF02_AG CRF37_cpx F CRF01_AE CRF37_cpx Ub DCRF02_AGa CRF02_AG URF A1 URF G URF
1
Kh R, Awazi B, Hewlett I: Increased genetic diversity and intersubtype recombinants of HIV-1 in blood donors from urban Cameroon. J Acquir Immune Defic Syndr 2007, 45:361?63. 6. Ndembi N, Abraha A, Pilch H, Ichimura H, Mbanya D, Kaptue L, Salata R, Arts EJ: Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mu
1
Tential impact of HIV-1 diversity on both vaccine development and the sustainability of antiretroviral therapies, it is particularly important that molecular epidemiological surveillance is continued in HIV diversity hotspots such as Cameroon. In this study we have focused on characterizing the diversity of gag and nef genes of Cameroonian HIV-1 isolates. These genes are?2013 Tongo et al.; license
1
Ibution of HIV-1 in CameroonSample ID BS01 BS02 BS03 BS04 BS05 BS06 BS09 BS10 BS11 BS12 BS13 BS14 BS16 BS18 BS19 BS20 BS21 BS22 BS23 BS24 BS25 BS26 BS27 BS29 BS30 BS31 BS32 BS35 BS38 BS39 BS40 BS42 BS43 BS44 BS45 BS46 BS47 BS48 BS49 BS50 BS51 BS53 BS54 BS55 gag gene CRF02_AG A-like G G CRF02_AG CRF02_AG CRF02_AG A1 CRF02_AG G CRF02_AG CRF02_AG CRF02_AG NDc CRF02_AG NDc CRF02_AG CRF02_AG CRF02_AG C
1
Use tissues[47]. There is a high correlation between NS1 concentration in patient sera and high concentrations of anaphylatoxins which suggests a role for NS1 in complement activation. Further, anaphylatoxins are co-localized to the lungs and plasma in dengue infections. Co-localization experiments with membrane bound NS1 and NS1 specific antibodies showed the formation of complement attack comple